Cases & Deals

Celgene develops patent portfolio for anti-CD47 therapeutic antibodies

Clients Celgene Corporation

Jones Day represented Celgene Corporation in the development of a portfolio of patents directed to anti-CD47 therapeutic antibodies.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.